Advertisement

CEN Case Reports

, Volume 8, Issue 1, pp 67–70 | Cite as

Ascorbic acid-induced oxalate nephropathy: a case report and discussion of pathologic mechanisms

  • Weijie Violet Lin
  • Christie Gloria TurinEmail author
  • David Walter McCormick
  • Christopher Haas
  • Gregory Constantine
Case Report
  • 78 Downloads

Abstract

Oxalate nephropathy is associated with hereditary hyperoxaluria, Crohn disease, and previous gastric or intestinal surgery, especially in the setting of increased oxalate intake or ethylene glycol ingestion. We present a patient whose intake of vitamin C supplements (2 g/day), exacerbated by predisposing factors of prior small bowel obstruction and resection, and benign prostate hyperplasia (BPH), resulted in acute kidney injury due to oxalate nephropathy. We review past reports of vitamin C-induced oxalate nephropathy and discuss the underlying precipitating factors.

Keywords

Acute renal failure Dialysis Vitamin C 

Notes

Acknowledgements

The authors are grateful to Bhuvaneswari Krishnan MD for pathology interpretation and Divya Janardhanan MD and Saed Shawar MD for their assistance in the medical care of this patient.

Compliance with ethical standards

Conflict of interest

The authors have declared that no conflicts of interest exists.

Human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

The subject’s identity has been masked. No identifying details are included in this manuscript to ensure complete anonymity.

References

  1. 1.
    Stokes MB. Acute oxalate nephropathy due to ethylene glycol ingestion. Kidney Int. 2006;69:203.CrossRefGoogle Scholar
  2. 2.
    Gurm H, Sheta MA, Nivera N, et al. Vitamin C-induced oxalate nephropathy: a case report. J Community Hosp Intern Med Perspect. 2012.  https://doi.org/10.3402/jchimp.v2i2.17718.Google Scholar
  3. 3.
    Lamarche J, Nair R, Peguero A, et al. Vitamin C-induced oxalate nephropathy. Int J Nephrol. 2011;2011:146927.CrossRefGoogle Scholar
  4. 4.
    Poulin LD, Riopel J, Castonguay V, et al. Acute oxalate nephropathy induced by oral high-dose vitamin C alternative treatment. Clin Kidney J. 2014;7:218.CrossRefGoogle Scholar
  5. 5.
    Cossey LN, Rahim F, Larsen CP. Oxalate nephropathy and intravenous vitamin C. Am J Kidney Dis. 2013;61:1032–5.CrossRefGoogle Scholar
  6. 6.
    Wong K, Thomson C, Bailey RR, et al. Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust N Z J Med. 1994;24:410–1.CrossRefGoogle Scholar
  7. 7.
    Duffey BG, Alanee S, Pedro RN, et al. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg. 2010;211:8–15.CrossRefGoogle Scholar
  8. 8.
    Chaudhari D, Crisostomo C, Ganote C, et al. Acute oxalate nephropathy associated with orlistat: a case report with a review of the literature. Case Rep Nephrol. 2013; 2013:124604.Google Scholar
  9. 9.
    Hellman L, Burns JJ. Metabolism of l-ascorbic acid-1-C14 in man. J Biol Chem. 1958;230:923–30.Google Scholar
  10. 10.
    Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA. 1996;93:3704–9.CrossRefGoogle Scholar
  11. 11.
    Knight J, Madduma-Liyanage K, Mobley JA, et al. Ascorbic acid intake and oxalate synthesis. Urolithiasis. 2016;44:289–97.CrossRefGoogle Scholar
  12. 12.
    Verkoelen CF, Verhulst A. Proposed mechanisms in renal tubular crystal retention. Kidney Int. 2007;72:13–8.CrossRefGoogle Scholar
  13. 13.
    Lawton JM, Conway LT, Crosson JT, et al. Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med. 1985;145:950–1.CrossRefGoogle Scholar
  14. 14.
    McHugh GJ, Graber ML, Freebairn RC. Fatal vitamin C-associated acute renal failure. Anaesth Intensive Care. 2008;36:585–8.Google Scholar
  15. 15.
    Mousson C, Justrabo E, Rifle G, et al. Piridoxilate-induced oxalate nephropathy can lead to end-stage renal failure. Nephron. 1993;63:104–6.CrossRefGoogle Scholar
  16. 16.
    Rathi S, Kern W, Lau K. Vitamin C-induced hyperoxaluria causing reversible tubulointerstitial nephritis and chronic renal failure: a case report. J Med Case Rep. 2007;1:155.CrossRefGoogle Scholar
  17. 17.
    Nasr SH, Kashtanova Y, Levchuk V, et al. Secondary oxalosis due to excess vitamin C intake. Kidney Int. 2006;70:1672.CrossRefGoogle Scholar
  18. 18.
    Alkhunaizi AM, Chan L. Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure. J Am Soc Nephrol. 1996;7:2320–6.Google Scholar
  19. 19.
    Worcester EM. Stones from bowel disease. Endocrinol Metab Clin N Am. 2002;31(4):979–99.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  • Weijie Violet Lin
    • 1
  • Christie Gloria Turin
    • 2
    Email author
  • David Walter McCormick
    • 2
  • Christopher Haas
    • 2
  • Gregory Constantine
    • 2
  1. 1.School of MedicineBaylor College of MedicineHoustonUSA
  2. 2.Department of MedicineBaylor College of MedicineHoustonUSA

Personalised recommendations